59
Views
187
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Helicobacter pylori Reduces the Rate of Rebleeding in Peptic Ulcer Disease

, , , &
Pages 939-942 | Received 23 Feb 1993, Accepted 28 Apr 1993, Published online: 08 Jul 2009

References

  • Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615–25
  • Graham D Y, Lew G M, Klein P D. Effect of treatment of Helicobacter pylori on the recurrence of gastric ulcers or duodenal ulcers: a randomized controlled study. Ann Intern Med 1992; 116: 705–8
  • Coghlan J G, Gilligan D, Humphries H. Campylobacter pylori and recurrence of duodenal ulcers–a 12-month follow-up study. Lancet 1987; 2: 1109–11
  • Lambert J R, Borromeo M, Korman M G, Hansky J, Eaves E R. Effect of colloidal bismuth (De-Nol) on healing and relapse of duodenal ulcers–role of Campylobacter pyloridis. Gastroenterology 1987; 92: 1489
  • Marshall B J, Goodwin C S, Warren J R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
  • Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–5
  • George L L, Borody T J, Andrews P. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145–9
  • Graham D Y, Lew G M, Evans D G, Evans D J, Jr., Klein P D. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing with ranitidine: a randomized controlled trial. Ann Intern Med 1991; 115: 266–9
  • Smith A C, Price A B, Borrielo P, Levi A J. A comparison of ranitidine and tripotassium dicitrato-bismuth (T.D.B.) in relapse rates of duodenal ulcer. The role of Campylobacter pylori (C.P.). Gastroenterology 1988; 94: A431
  • Serebro H A, Mendeloff A I. Late results of medical and surgical treatment of bleeding peptic ulcer. Lancet 1966; 2: 505–8
  • Graham D Y, Klein P D, Evans D J, Jr. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1987; 1: 1174–7
  • Evans D J, Jr, Evans D G, Graham D Y, Klein P D. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989; 96: 1004–8
  • Graham D Y, Lew G M, Malaty H M. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–6
  • Harvey R F, Langman M JS. The late results of medical and surgical treatment for bleeding duodenal ulcer. Q J Med 1970; 39: 539–47
  • Johansson C, Barany F. A retrospective study on the outcome of massive bleeding from peptic ulceration. Scand J Gastroenterol 1973; 8: 113–8
  • Smart H L, Langman M JS. Late outcome of bleeding gastric ulcers. Gut 1986; 27: 926–8
  • Hunt P S, Korman M G, Hansky J, Marshall R D, Peck G S, McCann W J. Bleeding duodenal ulcer: reduction in mortality with a planned approach. Br J Surg 1979; 66: 633–5
  • Preston J, Wormsley K G. Efficacy and safety of long-term maintenance therapy of duodenal ulcers. Scand J Gastroenterol 1989; 24: 1145–52
  • Elashoff J D, Van Deventer G, Reedy T J. Long-term follow-up of duodenal ulcer patients. J Clin Gastroenterol 1983; 5: 509–15
  • Egan J V, Jensen D M. Long-term management of patients with bleeding ulcers. Rationale, results, and economic impact. Gas-trointest Endosc Clin North Am 1991; 1: 367–85
  • Sontag S J. Current status of maintenance therapy in peptic ulcer disease. Am J Gastroenterol 1988; 83: 607–17
  • Jensen D M, Machicado G A, Kovacs T OG, Randall G M, Reedy T, CURE Hemostasis Research Group. Long-term recurrence of peptic ulceration and rebleeding with H2 maintenance, surgery, or no maintenance therapy. Gastroenterology 1989; 96: A239
  • Jensen D M, You S, Jensen M E. Randomized controlled study of ranitidine maintenance for patients with a recent severe duodenal ulcer hemorrhage. Gastroenterology 1990; 98: A65
  • Van Deventer G M, Elashoff J D, Reedy T J, Schneidman D, Walsh J H. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med 1989; 320: 1113–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.